All clinicians need to know how to use buprenorphine under the DEAs new regulations. Meanwhile, the fentanyl crisis is changing how we use it. Noah Capurso shows us how to navigate these waters.
Patient advocacy groups are adamant that it exists. European regulators have given it the stamp of approval. Here, we look at the evidence that sexual dysfunction can persist long after stopping an SSRI.
Listen to the full text of the issue read aloud by Gregory Malzberg, MD. It’s official. The DEA has conscripted all licensed clinicians to prescribe buprenorphine. Noah Capurso shows us how to do it. Meanwhile, Europe warns of post-SSRI sexual dysfunction, aerobic exercise enhances PTSD therapy, and new strategies for antipsychotic-induced hyperprolactinemia.
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
